Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Sangamo Therapeutics, Inc Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$1.66 - $3.67 $10,720 - $23,700	6,458 Added 9.28%	76,068 $133,000
Q4 2022 Feb 07, 2023	BUY	$2.77 - $5.07 $21,899 - $40,083	7,906 Added 12.81%	69,610 $218,000
Q3 2022 Nov 01, 2022	SELL	$4.27 - $6.39 $4,995 - $7,476	-1,170 Reduced 1.86%	61,704 $302,000
Q2 2022 Aug 04, 2022	BUY	$3.28 - $6.21 $95,549 - $180,903	29,131 Added 86.33%	62,874 $260,000
Q1 2022 May 09, 2022	BUY	$5.23 - $7.82 $15,072 - $22,537	2,882 Added 9.34%	33,743 $196,000
Q4 2021 Feb 07, 2022	BUY	$7.29 - $10.97 $14,434 - $21,720	1,980 Added 6.86%	30,861 $241,000
Q3 2021 Nov 04, 2021	BUY	$9.01 - $12.01 $7,027 - $9,367	780 Added 2.78%	28,881 $260,000
Q2 2021 Aug 06, 2021	SELL	$10.17 - $12.64 $63,918 - $79,442	-6,285 Reduced 18.28%	28,101 $336,000
Q1 2021 May 06, 2021	BUY	$10.88 - $17.05 $124,293 - $194,779	11,424 Added 49.75%	34,386 $431,000
Q4 2020 Feb 09, 2021	BUY	$9.23 - $18.18 $56,293 - $110,879	6,099 Added 36.17%	22,962 $358,000
Q3 2020 Nov 10, 2020	SELL	$9.38 - $12.48 $7,747 - $10,308	-826 Reduced 4.67%	16,863 $159,000
Q2 2020 Aug 06, 2020	SELL	$6.21 - $11.83 $2,651 - $5,051	-427 Reduced 2.36%	17,689 $158,000
Q1 2020 May 11, 2020	BUY	$5.05 - $8.85 $17,356 - $30,417	3,437 Added 23.41%	18,116 $115,000
Q4 2019 Feb 05, 2020	BUY	$8.03 - $11.7 $1,622 - $2,363	202 Added 1.4%	14,679 $121,000
Q3 2019 Nov 12, 2019	BUY	$9.05 - $12.22 $22,760 - $30,733	2,515 Added 21.02%	14,477 $131,000
Q2 2019 Aug 08, 2019	SELL	$8.75 - $13.03 $24,237 - $36,093	-2,770 Reduced 18.8%	11,962 $129,000
Q1 2019 Apr 26, 2019	BUY	$7.72 - $12.81 $5,928 - $9,838	768 Added 5.5%	14,732 $141,000
Q4 2018 Feb 08, 2019	BUY	$9.51 - $16.6 $43,736 - $76,343	4,599 Added 49.11%	13,964 $154,000
Q3 2018 Nov 13, 2018	BUY	$13.05 - $19.05 $122,213 - $178,403	9,365 New	9,365 $159,000

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account